Tailored, dense-dose chemotherapy for early breast cancer does not result in significant improvement
Among women with high-risk early breast cancer, the use of tailored dose-dense chemotherapy compared with standard adjuvant chemotherapy did not result in a statistically significant improvement in breast cancer recurrence-free ...
Nov 8, 2016